Catalyst Wire Dossier Catalyst Wire Dossier

OCS-01 Eye Drops

OCS-01 · Oculis
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for OCS-01 Eye Drops, covering 2024-12-10 to 2026-01-13. Get the full timeline:

Most recent: Clinical Trial Update: A Pivotal Safety and Efficacy Study of OCS-01 Eye Drops in Participants With Diabetic Macular Edema (DIAMOND 2) [Phase 3]

See pricing